TWDBTaiwan Manufacturer Database 中文

EIRGENIX, INC.

台康生技股份有限公司

Get an email when something changes (or just keep it in this browser without an email).

My watchlist →

2012Founded
NT$3.1BPaid-in capital
2Plants
2Patents
NT$1–5BRevenue band
Unified Business No.
54150737
Industry
Pharmaceuticals & Medicinal Chemicals (273)
Main products
Pharmaceuticals & medicinal chemicals (276)
Location
No. 101, Ln. 169, Kangning St., Xizhi Dist., New Taipei City 221013, Taiwan (R.O.C.)
New Taipei City (16,829) · Xizhi Dist. (1,300)
Listing
Listed (TWSE) (1,087) 6589
Registration status
Approved / Active
Organisation type
Company Limited by Shares
Founded
2012-12-21
Paid-in capital
NT$ 3,068,711,740
Representative
Liu Li-cheng
Phone
(02)7708-0123
Website
http://www.eirgenix.com
Exporter
Yes — registered with the Trade Administration
Annual revenue band
NT$1–5B
Ownership
Group subsidiary / corporate-held · FOXCONN TECHNOLOGY CO., LTD.、FORMOSA LABORATORIES, INC.、Hsing Cheng Yuan Kuo Chia Fa Chan Chi Chin Kuan Li Huei、Yao Hua Po Li Ku Fen Yu Hsien Kung Szu Kuan Li Wei Yuan Huei
Representative tenure
In office since 2022-07 (4 yrs); last handover 2022-07
Growth & profitability
Revenue 2026-09 YoY +43.2%, year-to-date +73.6%
Gross margin 32.7%, operating margin -65.9%, net margin -54.2% (2026-Q2 YTD)

Plants 2

Processes & materials 1

Patents 2

  • 2025 CRM197 protein expression
  • 2024 Pharmaceutical composition comprising anti-HER2 antibody for subcutaneous administration

Similar companies 10

Ranked by overlap in processes and materials, registered business activities, certifications and main products; rarer shared traits weigh more. Dissolved companies are excluded.

Open in advanced filters →